FDG-PET Assessment of Other Gynecologic Cancers

PET Clin. 2018 Apr;13(2):203-223. doi: 10.1016/j.cpet.2017.11.006.

Abstract

PET and PET/computed tomography play a role in the staging, monitoring of response to therapy, and surveillance for cervical and ovarian cancers. Currently, it is also an integral part of the assessment of patients with endometrial cancer and other gynecologic malignancies, such as vaginal and vulvar cancers and uterine sarcomas. In this article, we discuss in detail and highlight the potential role of PET and PET/computed tomography in evaluating these gynecologic malignancies using illustrative cases with relevant imaging findings.

Keywords: Endometrial cancer; Positron emission tomography (PET); Positron emission tomography/computed tomography (PET/CT); Uterine cancer; Uterine sarcoma; Vaginal cancer; Vulvar cancer.

Publication types

  • Review

MeSH terms

  • Aged
  • Aged, 80 and over
  • Endometrial Neoplasms / diagnostic imaging
  • Endometrial Neoplasms / pathology
  • Female
  • Fluorodeoxyglucose F18*
  • Genital Neoplasms, Female / diagnostic imaging*
  • Genital Neoplasms, Female / pathology*
  • Humans
  • Middle Aged
  • Neoplasm Invasiveness / pathology
  • Neoplasm Staging
  • Positron Emission Tomography Computed Tomography / methods
  • Positron-Emission Tomography / methods*
  • Radiographic Image Enhancement*
  • Sensitivity and Specificity
  • Uterine Neoplasms / diagnostic imaging
  • Uterine Neoplasms / pathology
  • Vaginal Neoplasms / diagnostic imaging
  • Vaginal Neoplasms / pathology
  • Vulvar Neoplasms / diagnostic imaging
  • Vulvar Neoplasms / pathology

Substances

  • Fluorodeoxyglucose F18